Venture
Technologies
Diagnostic
Indication
Allergy/Asthma
Autoimmune & Inflammation
Basic Research
Cardiovascular Disease
Central Nervous System Disorders
Clinical Research
Clinical Trials
Dermatology
Developmental Disorders
Disease Surveillance
Education
Fibrosis
Genetics & Genomics
Metabolic Disease
Molecular Diagnostic
Musculoskeletal Disorders
Nephrology
Neurodegenerative Disease
Obesity
Oncology
Orphan Diseases
Personalized Medicine
Women’s health
Additional Information
Women Founded
Revolutionizing Prenatal Care, Pre-life is a noninvasive whole genome test that detects genetic diseases of the fetus at 10 weeks from the mother’s blood for prevention and treatment at pre-life.
Pre-Life Team: